From the Benzinga conference in Miami, we catch up with MariMed (CNSX: MRMD OTC: MRMD) Chief Executive Officer Jon Levine and CFO Susan Villare join us to discuss how the company is maintaining bullish sentiment, and winning the market despite the industry’s distress. Amidst adversity for the sector, MariMed’s high-quality products continue to be a key success, reaching $150 million revenue per their Q1 earnings report.

We also discuss the company’s key strategies and discipline along with market trends investors can anticipate this year, and their plans on expansion and acquisition involving companies that could face bankruptcy in the upcoming debt cliffs.

CEO Jon Levine brings years of real estate experience to MariMed, and is one of the reasons why the company has performed a competitive edge versus its peers, making timely decisions on key locations in 6 states.